BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 30977034)

  • 1. A proposed pathologic sub-classification of drug-induced liver injury.
    Wang T; Zhao X; Shao C; Ye L; Guo J; Peng N; Zhang H; Li J; Kong Y; You H; Jia J
    Hepatol Int; 2019 May; 13(3):339-351. PubMed ID: 30977034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency and pathological characteristics of drug-induced liver injury in a tertiary medical center.
    Ettel M; Gonzalez GA; Gera S; Eze O; Sigal S; Park JS; Xu R
    Hum Pathol; 2017 Oct; 68():92-98. PubMed ID: 28873351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and pathological features in 138 cases of drug-induced liver injury].
    Lai RT; Wang H; Gui HL; Ye MZ; Dai WJ; Xiang XG; Zhao GD; Wang WJ; Xie Q
    Zhonghua Gan Zang Bing Za Zhi; 2012 Mar; 20(3):185-9. PubMed ID: 22475136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations.
    Kleiner DE; Chalasani NP; Lee WM; Fontana RJ; Bonkovsky HL; Watkins PB; Hayashi PH; Davern TJ; Navarro V; Reddy R; Talwalkar JA; Stolz A; Gu J; Barnhart H; Hoofnagle JH;
    Hepatology; 2014 Feb; 59(2):661-70. PubMed ID: 24037963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of liver biopsy in the era of clinical prediction scores for "drug-induced liver injury" (DILI): experience of a tertiary referral hospital.
    Costa-Moreira P; Gaspar R; Pereira P; Lopes S; Canão P; Lopes J; Carneiro F; Macedo G
    Virchows Arch; 2020 Oct; 477(4):517-525. PubMed ID: 32377873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serological and pathological features of drug-induced liver injury and autoimmune hepatitis].
    Jiang ZL; Li P; Wang JL; Yang QH; Liu YG; Shi RF; Mi YQ
    Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):810-816. PubMed ID: 27978925
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical analysis of 2 820 cases of drug-induced liver injury].
    Song FJ; Zhai QH; He QJ; Lyu S; Zhu B; Xu TJ; Tian H; Xin SJ; You SL
    Zhonghua Gan Zang Bing Za Zhi; 2020 Nov; 28(11):954-958. PubMed ID: 33256282
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and pathological analysis of 100 cases of drug-induced liver injury].
    Zhou GD; Zhao JM; Zhang LX; Sun YL; Pan D; Yang JF; Zhao YL
    Zhonghua Gan Zang Bing Za Zhi; 2007 Mar; 15(3):212-5. PubMed ID: 17407714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical features of drug-induced autoimmune hepatitis and drug-induced liver injury: a comparative analysis].
    Zhao SX; Zhang YG; Tan PF; Wang RQ; Nan YM
    Zhonghua Gan Zang Bing Za Zhi; 2016 Apr; 24(4):302-6. PubMed ID: 27470631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of gender and a proxy of female menopausal status with histological features of drug-induced liver injury.
    Suzuki A; Barnhart H; Gu J; Bonkovsky HL; Tillmann HL; Fontana RJ; Kleiner DE;
    Liver Int; 2017 Nov; 37(11):1723-1730. PubMed ID: 28161910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel MicroRNA Signature for Cholestatic Drugs in Human Hepatocytes and Its Translation into Novel Circulating Biomarkers for Drug-Induced Liver Injury Patients.
    López-Riera M; Conde I; Castell JV; Jover R
    Toxicol Sci; 2020 Feb; 173(2):229-243. PubMed ID: 31198949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics of Patients with Drug-induced Liver Injury.
    Yang LX; Liu CY; Zhang LL; Lai LL; Fang M; Zhang C
    Chin Med J (Engl); 2017 Jan; 130(2):160-164. PubMed ID: 28091407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-Induced Liver Injury: Clinical and Etiologic Features at a Large Tertiary Teaching Hospital in China.
    Liu Y; Zhan SP; Song L; Chen Y; Jia YT; Liu F; Sun FJ; Wang Q; Xia PY
    Med Sci Monit; 2020 Mar; 26():e919435. PubMed ID: 32172275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histologic pattern is better correlated with clinical outcomes than biochemical classification in patients with drug-induced liver injury.
    Tian QJ; Zhao XY; Wang Y; Wee A; Soon GST; Gouw ASH; Li M; Yang RY; Wang L; Wang QY; Duan WJ; Wang Y; Wang XM; Kong YY; Ou XJ; You H; Jia JD
    Mod Pathol; 2019 Dec; 32(12):1795-1805. PubMed ID: 31300804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of Drug- and Herb-Induced Liver Injury Assessed for Causality Using the Updated RUCAM in Two Hospitals from China.
    Chen Y; Wang C; Yang H; Huang P; Shi J; Tong Y; Jiang J; Zhang X; Chen W; Xuan Z
    Biomed Res Int; 2021; 2021():8894498. PubMed ID: 33954202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Features and outcomes from a retrospective study of 570 hospitalized Chinese patients with drug-induced liver injury.
    Pang L; Yang W; Hou F
    Clin Res Hepatol Gastroenterol; 2018 Feb; 42(1):48-56. PubMed ID: 28927656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical characteristics of drug-induced liver injury and primary biliary cirrhosis.
    Yang J; Yu YL; Jin Y; Zhang Y; Zheng CQ
    World J Gastroenterol; 2016 Sep; 22(33):7579-86. PubMed ID: 27672278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes.
    Quintás G; Martínez-Sena T; Conde I; Pareja Ibars E; Kleinjans J; Castell JV
    Arch Toxicol; 2021 Sep; 95(9):3049-3062. PubMed ID: 34274980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry.
    Medina-Caliz I; Garcia-Cortes M; Gonzalez-Jimenez A; Cabello MR; Robles-Diaz M; Sanabria-Cabrera J; Sanjuan-Jimenez R; Ortega-Alonso A; García-Muñoz B; Moreno I; Jimenez-Perez M; Fernandez MC; Ginés P; Prieto M; Conde I; Hallal H; Soriano G; Roman E; Castiella A; Blanco-Reina E; Montes MR; Quiros-Cano M; Martin-Reyes F; Lucena MI; Andrade RJ;
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1495-1502. PubMed ID: 29307848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The value of serum aspartate aminotransferase and gamma-glutamyl transpetidase as biomarkers in hepatotoxicity.
    Robles-Diaz M; Garcia-Cortes M; Medina-Caliz I; Gonzalez-Jimenez A; Gonzalez-Grande R; Navarro JM; Castiella A; Zapata EM; Romero-Gomez M; Blanco S; Soriano G; Hidalgo R; Ortega-Torres M; Clavijo E; Bermudez-Ruiz PM; Lucena MI; Andrade RJ; ;
    Liver Int; 2015 Nov; 35(11):2474-82. PubMed ID: 25809419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.